Tolerance and outcomes of stereotactic radiosurgery combined with anti-PD1 (pembrolizumab) for melanoma brain metastases

Authors :: C. Robert
M. Texier
Samy Ammari
C. Nardin
Emilie Lanoy
F. Dhermain
S. Hibat-Allah
Christine Mateus
Source :: Annals of Oncology. 28:v444-v445
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
business.industry
medicine.medical_treatment
Melanoma
Hematology
Pembrolizumab
medicine.disease
Radiosurgery
Surgery
Internal medicine
medicine
business
Anti pd1

Tools